take both a GLP-1 agonist (Byetta, etc) and DPP-4 inhibitor (Januvia, etc) for type 2 diabetes
Is it okay for patients to take both a GLP-1 agonist (Byetta, etc) and DPP-4 inhibitor (Januvia, etc) for type 2 diabetes?
This is sometimes tried if patients need combo therapy and they want to avoid weight gain or hypoglycemia from other meds.
GLP-1 agonists mimic incretin hormones...while DPP-4 inhibitors, or "gliptins," prevent the breakdown of endogenous incretins.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote